enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Chemotherapy-induced nausea and vomiting - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy-induced...

    The newest 5-HT 3 inhibitor, palonosetron (Aloxi), also prevents delayed nausea and vomiting, which can occur during the 2–5 days after treatment. Since some patients have trouble swallowing pills, these drugs are often available by injection, as orally disintegrating tablets, or as transdermal patches.

  3. Cancer and nausea - Wikipedia

    en.wikipedia.org/wiki/Cancer_and_nausea

    Cancer and nausea are associated in about fifty percent of people affected by cancer. [1] This may be as a result of the cancer itself, or as an effect of the treatment such as chemotherapy, radiation therapy, or other medication such as opiates used for pain relief. About 70–80% of people undergoing chemotherapy experience nausea or vomiting.

  4. Rolapitant - Wikipedia

    en.wikipedia.org/wiki/Rolapitant

    Rolapitant is used in combination with other antiemetic (anti-vomiting) agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. [1]

  5. Chemoreceptor trigger zone - Wikipedia

    en.wikipedia.org/wiki/Chemoreceptor_trigger_zone

    The neurotransmitters implicated in the control of nausea and vomiting include acetylcholine, dopamine, histamine (H1 receptor), substance P (NK-1 receptor), and serotonin (5-HT3 receptor). There are also opioid receptors present, which may be involved in the mechanism by which opiates cause nausea and vomiting.

  6. NK1 receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/NK1_receptor_antagonist

    The discovery of neurokinin 1 (NK 1) receptor antagonists was a turning point in the prevention of nausea and vomiting associated with cancer chemotherapy. [4] An example of a drug in this class is aprepitant. Chemotherapy-induced emesis appears to consist of acute and delayed phases.

  7. U.S. cancer patients face nationwide shortages of life-saving ...

    www.aol.com/finance/u-cancer-patients-face...

    The U.S. Food and Drug Administration (FDA) tells Fortune it is working with manufacturers like Fresenius Kabi to mitigate the shortage of chemotherapy drugs, but it lacks the authority to compel ...

  8. Palonosetron - Wikipedia

    en.wikipedia.org/wiki/Palonosetron

    Palonosetron, sold under the brand name Aloxi, is a medication used for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). [2] [4] [5] It is a 5-HT 3 antagonist. [2] [4] [5] Palonosetron is administered intravenously, [6] or as a single oral capsule. [7] It has a longer duration of action than other 5-HT 3 antagonists.

  9. Ozempic Users Are Noticing A Surprising Side Effect ... - AOL

    www.aol.com/ozempic-users-noticing-surpising...

    And in studies conducted on another popular weight loss drug called terzepatide (aka, Mounjaro), 5.7 percent of patients reported experiencing hair loss versus less than 1 percent on a placebo. So ...